Details for New Drug Application (NDA): 202929
✉ Email this page to a colleague
The generic ingredient in ESZOPICLONE is eszopiclone. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the eszopiclone profile page.
Summary for 202929
Tradename: | ESZOPICLONE |
Applicant: | Macleods Pharms Ltd |
Ingredient: | eszopiclone |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 202929
Suppliers and Packaging for NDA: 202929
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ESZOPICLONE | eszopiclone | TABLET;ORAL | 202929 | ANDA | Macleods Pharmaceuticals Limited | 33342-299 | 33342-299-07 | 30 TABLET, FILM COATED in 1 BOTTLE (33342-299-07) |
ESZOPICLONE | eszopiclone | TABLET;ORAL | 202929 | ANDA | Macleods Pharmaceuticals Limited | 33342-299 | 33342-299-11 | 100 TABLET, FILM COATED in 1 BOTTLE (33342-299-11) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
Approval Date: | Jan 30, 2015 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
Approval Date: | Jan 30, 2015 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 3MG | ||||
Approval Date: | Jan 30, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription